Andrew Gibbs serves as Executive at Myriad Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Gibbs has executed 3 insider transactions totaling $4.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 24, 2010 involved receiving (via award) 12,000 shares valued at $0.
Andrew Gibbs currently holds 19,847 shares of Myriad Pharmaceuticals, Inc. (MYRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Gibbs has been a net seller of MYRX stock. They have purchased $0 and sold $4.4K worth of shares.
Andrew Gibbs's most recent insider trade was on Sep 24, 2010, when they sold 12,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.78 |
| Discretionary |
| Jul 1, 2009 | MYRX | $0 | Award | 9,000 | $N/A | Discretionary |